Joint Oxford, Sputnik vaccine launch!

Contracted companies
To determine the effectiveness of a mixed vaccine.

London: The University of Oxford and Russia have decided to combine different vaccines with Kovid-19. Research teams from both countries will join hands for this. Both vaccines are based on adenovirus. The vaccine, jointly developed by Oxford and Estrogen, has not yet received government approval. The Sputnik vaccine, developed by scientists at the Gamalaya Research Institute in Russia, is already in use. Researchers are still struggling to gather enough evidence before reaching the final conclusions about the effectiveness of the combination of the two vaccines. AstraZeneca responded positively to a proposal made by Gamalea. The two companies have reached an agreement. Using a combination of different types of vaccines may be key to better protection against measles, Gamalea said. It said it would be a new chapter in terms of cooperation on vaccines. Final trials have shown that the Sputnik vaccine provides 90 percent protection. In the case of the Oxford vaccine, it is revealed that 62% protection is obtained with one dosage and 90% with another type of dose.